Division News

Lyman on changes in breast cancer treatments

Gary Lyman, MD, MPH, professor of medicine (Medical Oncology), on camera at the San Antonio Breast Cancer Symposium in December talking about the BOLERO-2 trial as a potentially practice-changing development in the field of breast cancer. He added that more agents are needed for the treatment of advanced metastatic disease.

Putting Trials to the Test

Duke Magazine feature on Avastin: While a doctor's own experience is one guide to medical care, the evidence from clinical trials may be a better guide. But how much better? With quotes from Gary Lyman, Kim Blackwell, Robert Harrington and Eric Peterson of the Department of Medicine.